Hope For Stomach Cancer

Join Us for Day 3 of the Stomach Cancer Patient Empowerment Summit! We’re live for the final day of the summit! Today’s sessions are packed with insightful discussions, expert panels, and empowering stories from patients and advocates. Date: February 10, 2025 Time: 8:30 AM PST | 11:30 AM EST ?? Day 3 Schedule: https://lnkd.in/gutF6M4g ?? Watch Live on YouTube: https://lnkd.in/gnfVmEtN Don’t miss this opportunity to learn, connect, and make a difference in the stomach cancer community. Tune in now! #StomachCancerAwareness #PatientEmpowerment #HopeForStomachCancer

Day 2 of the HOPE Patient Empowerment Summit is live! Join us for another impactful day of expert insights, patient stories, and discussions on stomach cancer awareness and advocacy. Date: February 9, 2025 Time: 8 AM PST | 11 AM EST Full Agenda: https://lnkd.in/gutF6M4g Watch the Live Stream: https://lnkd.in/gs3spTbH Don’t miss this opportunity to learn, connect, and be part of the movement for change. #HopeSummit2025 #StomachCancerAwareness #PatientEmpowerment #HOPEforStomachCancer

?? The Wait is Over – Day 1 of the Patient Empowerment Summit is Here! ?? Join us for an inspiring and informative day as we kick off the HOPE Patient Empowerment Summit 2025! ????? ?? Date: February 8, 2025 ?? Location: YouTube Live ?? Full Agenda: https://lnkd.in/gxKTnqdc ?? Watch the Live Stream Day 2 PST | 5pm EST : https://lnkd.in/gbTSRVry Don’t miss powerful discussions, expert insights, and patient stories that will inspire hope and action! Let’s unite for change and make an impact together. ???? #HopeSummit2025 #StomachCancerAwareness #PatientEmpowerment #HOPEforStomachCancer

The recent fires in Los Angeles County have disrupted medical services and displaced many in our community, including stomach cancer patients in critical need of care. These individuals are facing interruptions in their treatment, adding an immense burden to an already challenging journey. Moasc is asking for help to ensure continuity of care. How You Can Support: ? Healthcare providers and facilities: If you can temporarily see patients from the affected areas, please reach out. ? Share your availability and scheduling details to coordinate care. Contact [email protected] Your assistance can make a life-changing difference during this difficult time. Together, we can help these patients stay on track with their treatment. ?? Additional Resources: CancerCare https://lnkd.in/eRP2SyP Cedars Sinai https://lnkd.in/gmRBxHxq UCLA Health https://lnkd.in/eJVTC8c USC Arcadia Thank you for standing with us to provide hope and healing when it’s needed most. ?? #HopeForStomachCancer #LosAngelesFires #CommunityCare

FDA Approves Tislelizumab (Tevimbra) Plus Chemo for PD-L1+ Gastric/GEJ Cancer We’re excited to share a major breakthrough in stomach cancer treatment! The FDA has approved?tislelizumab (Tevimbra)?combined with platinum- and fluoropyrimidine-based chemotherapy as a?first-line treatment?for patients with unresectable or metastatic, HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors express?PD-L1 (≥1). Why this matters: The approval is based on the results of the phase 3 RATIONALE-305 trial, which showed a significant improvement in overall survival (OS) for patients receiving tislelizumab plus chemotherapy. Key Highlights: Improved Survival Rates:?Tislelizumab offers a meaningful advancement in treatment options for patients with advanced gastric/GEJ cancers. Enhanced Outcomes:?The trial also demonstrated better progression-free survival (PFS) and response rates. “This approval represents a significant step forward in addressing the unmet needs of stomach cancer patients,” said Dr. Mark Lanasa, Chief Medical Officer, Solid Tumors at BeiGene. Mark Lanasa, MD, PhD, Chief Medical Officer of Solid Tumors at BeiGene; Aki Smith, Founder of Hope for Stomach Cancer; and Dr. Nataliya Uboha, MD, PhD, a leading oncologist from the University of Wisconsin-Madison School of Medicine and Public Health and UW Health, are captured together at the FDA Oncology Center of Excellence (OCAD) hearing on September 26, 2024. The trio stands proudly, reflecting their shared commitment to advancing stomach cancer research and treatment. The moment highlights a significant gathering of experts and advocates working together to push for innovation and improved patient care.

?? End of Year Candlelight Tribute ?? Each year, we honor and remember our loved ones with a special candlelight tribute. We include their photos, names, and birth years to keep their light shining. If you would like your loved one to be included in this year’s tribute, please send the following information to [email protected]: ? Name ? Photo ? Birth Year Your support helps us ensure that no one is forgotten. Together, we honor their memory and the strength they inspire. ?? Deadline: December 23rd Thank you for being a part of this meaningful tradition. ??

Tonight is our Stomach Cancer Support Group! Will you be there? If you’re a patient or caregiver navigating stomach cancer or GEJ, join us! Get the latest treatment updates, discuss new ideas, and connect with others. Dr. Sam Klempner, GI Oncologist at Mass General, will be moderating. RSVP here:

We invite you to explore our YouTube channel where we share powerful patient stories, expert insights, and valuable resources about stomach cancer and its impact. ?? ? Watch real-life stories of strength and resilience. ? Learn from medical professionals about the latest treatments and support options. ? Join a community of survivors, caregivers, and advocates. Check it out: https://lnkd.in/gwujkz4Q

?? ??

Are you registered for the Patient Empowerment Summit & Advocacy Day? Join us in DC February 8 - 11 for this incredible opportuinty to network, build community, and advocate for better treatments and options for stomach cancer patients. Learn more at stomachcancerdc.org and don't forget to book your hotel room!